News

KBRA Unveils Initial Ratings for 2024-V10 CMBS Transaction

KBRA Unveils Initial Ratings for 2024-V10 CMBS Transaction

KBRA Announces Ratings for Benchmark 2024-V10

KBRA is pleased to announce the preliminary ratings for 13 classes of the Benchmark 2024-V10, a noteworthy $738.0 million commercial mortgage-backed securities (CMBS) conduit transaction. This deal is backed by a total of 32 commercial mortgage loans, all secured by 100 separate properties, showcasing the agency's strong presence within the CMBS market.

Overview of the Collateral Properties

The properties linked to this extensive pool span across 18 metropolitan statistical areas (MSAs), which demonstrates a well-thought-out geographic diversity. Among these, the largest markets contributing significant value include New York, Los Angeles, and Honolulu, which account for 26.5%, 15.3%, and 9.3% of the total property value, respectively. This varied composition not only opens up substantial market opportunities but also distributes the risk among different major property types.

Main Property Types in the Portfolio

The pool features a broad array of property types; mixed-use properties make up 28.1% of the total, followed by multifamily units at 26.3%, office spaces contributing 20.5%, and retail properties at 10.3%. This diversity is essential in balancing the overall risk and potential returns of the transaction.

Loan Principal Balances Overview

The principal balances of loans in this transaction vary greatly, ranging from $5.0 million to an impressive $73.5 million. The largest loan, known as the BioMed 2024 Portfolio 2, includes seven life science and office properties, along with one parking garage. Additionally, the top five loans include notable properties such as the Hyatt Centric Hotel & Shops Waikiki Beach, Culver Collection, Bronx Terminal Market, and Moffett Towers Building D, together representing 42.7% of the initial pool.

KBRA's Analysis and Methodology

KBRA employs a detailed analysis approach for all transactions, beginning with an exhaustive review of the financial performance and operational metrics of the underlying properties. By using this method, the agency estimates sustainable net cash flow (KNCF) and determines property values based on its North American CMBS Property Evaluation Methodology.

Explaining KNCF and Valuation Methods

As part of its analysis, KBRA determined that the overall KNCF was roughly 12.9% lower than what the issuer had projected for cash flow. To establish asset values, various capitalization rates were applied to each asset’s KNCF, leading to values that, on average, fell 38.5% below third-party appraisal values. Key performance metrics like the in-trust KLTV and all-in KLTV were reported at 91.4% and 97.9%, respectively, indicating a considerable level of refinancing risk.

Calculating Default Risk

The structured model that KBRA uses incorporates rigorous stress tests for rent and occupancy, alongside default probability regressions. This critical data is necessary for calculating the loss given default for each collateral loan, thus enabling the accurate assignment of credit ratings that reflect the portfolio's underlying risk.

Access More Details

Those interested in exploring detailed ratings and associated documentation for this transaction can find the relevant materials through KBRA's official channels.

About KBRA

Kroll Bond Rating Agency, LLC, commonly known as KBRA, is a comprehensive credit rating agency registered with the U.S. Securities and Exchange Commission. Its affiliates are also registered in Europe and the UK, illustrating the broad reach and authority of KBRA in the credit ratings arena. The agency's recognition as an official rating organization by the Ontario Securities Commission and validation by the National Association of Insurance Commissioners emphasizes its credibility and importance in the industry.

Frequently Asked Questions

What is the Benchmark 2024-V10 transaction?

The Benchmark 2024-V10 is a $738.0 million CMBS conduit transaction backed by 32 commercial mortgage loans that are secured by 100 properties.

What types of properties are included in the collateral?

The collateral features various property types, with significant contributions from mixed-use, multifamily, office, and retail segments.

How are credit ratings assigned in KBRA's analysis?

KBRA assigns credit ratings through a careful evaluation of the financial performance of the properties to estimate sustainable net cash flow and apply valuation methodologies.

What does KNCF represent in the transaction?

KNCF stands for sustainable net cash flow, which is a key metric in assessing the value and creditworthiness of the properties involved.

Where can I find more information about KBRA’s ratings?

More information and access to ratings can be found on KBRA's official website and in their published documents.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

NATSO, SIGMA Push for '45Z' Credit Transparency

Updated Category News Views 2

The Push for Transparency in Biofuel Tax Credits With diesel prices hitting new heights and biofuel players scrambling for their slice of the pie, NATSO and SIGMA are stepping up to the plate, urging the U.S. Treasury Department to shine a flashlight on the murky 'Section 45Z' Clean Fuel Production Tax Credit. They're not doing this out of some idealistic notion but...

Continue Reading
Insights on Early Redemptions in Jyske Realkredit Bonds

Updated Category News Views 90

Understanding Preliminary Data on Early Redemptions In a recent communication to Nasdaq Copenhagen A/S, Jyske Realkredit announced preliminary data regarding early redemptions, or prepayments, of their issued bonds. This announcement serves to inform investors and stakeholders about the ongoing performance and liquidity options associated with these financial instruments....

Continue Reading
Standard Dental Labs Expands Acquisition Strategy in Florida

Updated Category News Views 158

Overview of Recent Developments at Standard Dental Labs Standard Dental Labs Inc. (OTCQB: TUTH), a consolidator of dental laboratories, has recently made headlines by signing five letters of intent (LOIs) to acquire privately-owned dental labs. This move marks a pivotal progression in the company’s acquisition strategy. By actively targeting dental laboratories based in...

Continue Reading
MediLink's YL201 Shines at ESMO Congress for Cancer Treatment

Updated Category News Views 77

MediLink's Promising Presentation of YL201 at ESMO 2024 MediLink Therapeutics made a notable impression at the recent ESMO Congress by revealing clinical data for YL201, an innovative antibody-drug conjugate (ADC) that targets B7-H3. This presentation marked the first time clinical results for YL201 were shared publicly, showcasing the drug's significant potential in...

Continue Reading
Anthony Scaramucci Praises Solana as Crypto's Brightest Star

Updated Category News Views 231

Anthony Scaramucci Champions Solana Anthony Scaramucci, founder and managing partner of SkyBridge Capital, has given a resounding endorsement to Solana, labeling it as the "fastest-growing app ecosystem on earth." His enthusiastic remarks came as he promoted his latest book, titled "Solana Rising: Investing in the Fast Lane of Crypto." In this book, Scaramucci delves into...

Continue Reading